AVL9 and lung adenocarcinoma: Experimental evidence indicates that the interaction between ALMS1‐IT1 and AVL9 may contribute to the malignant advancement of Lung Adenocarcinoma (LUAD) by influencing the cyclin‐dependent kinase pathway.27